Literature DB >> 24554418

Cerebral venocclusive disease due to CNS T cell lymphoma.

J A Matias-Guiu1, O Rodríguez-Gómez, J C Plaza, A Marcos-Dolado, J Porta-Etessam.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24554418     DOI： 10.1007/s10072-014-1684-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  7 in total

Review 1.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

2.  Primary central nervous system lymphoma: coming or going?

Authors:  Lisa M DeAngelis
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

3.  Lymphoma as a cause of isolated oculomotor nerve palsy.

Authors:  Hiromasa Sato; Takao Hashimoto; Suguru Yoneda; Kazuko Hirabayashi; Kazuhiro Oguchi; Kayoko Higuchi
Journal:  J Clin Neurosci       Date:  2011-07-02       Impact factor: 1.961

4.  Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.

Authors:  Tamara N Shenkier; Jean-Yves Blay; Brian Patrick O'Neill; Philip Poortmans; Eckhard Thiel; Kristoph Jahnke; Lauren E Abrey; Edward Neuwelt; Richard Tsang; Tracy Batchelor; Nancy Harris; Andrés J M Ferreri; Maurilio Ponzoni; Peter O'Brien; James Rubenstein; Joseph M Connors
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  The neurological masquerade of intravascular lymphomatosis.

Authors:  Xabier Beristain; Biagio Azzarelli
Journal:  Arch Neurol       Date:  2002-03

6.  Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis.

Authors:  Netta Levin; Dov Soffer; Sigal Grissaru; Natasha Aizikovich; J Moshe Gomori; Tali Siegal
Journal:  J Neurooncol       Date:  2008-07-01       Impact factor: 4.130

Review 7.  Primary central nervous system lymphoma: an update.

Authors:  Carole Soussain; Khê Hoang-Xuan
Journal:  Curr Opin Oncol       Date:  2009-11       Impact factor: 3.645
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.